Pancreatic Cancer Research

ResearcherFourth Hospital of Hebei Medical UniversityActive in the last 2 years

Ningning Feng

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-5544-0025; OpenAlex author ID A5106578945.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
2
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. Long non-coding RNA MIR600HG as a ceRNA inhibits the pancreatic cancer progression through regulating the miR-1197/PITPNM3 axis. Co-author DOI 10.1016/j.heliyon.2024.e24546↗
  2. Hsa_circ_0050102 regulates the pancreatic cancer development via miR-218-5p/PPME1 axis. First author DOI 10.1002/jcla.24247↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Baoming Yang · 2 shared papers, 2022–2024
  2. Shunxiang Wang · 1 shared paper, 2024

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.